American Cancer Society outlines blueprint for cancer control in the 21st century

July 10, 2018

The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that begins publishing today. The series of articles forms the basis of a national cancer control plan; a blueprint toward the control of cancer and a mortality reduction goal for the year 2035.

"It is our hope that this blueprint will be a call to action for cancer patients, family members of cancer patients, professional organizations, government agencies, the medical profession, academia, and industry to work together to implement what is known about cancer control," write the authors, led by Chief Medical Officer Otis W. Brawley, M.D., MACP. The series is being published in CA: A Cancer Journal for Clinicians.

Despite a 25-year decline in mortality rate, cancer remains the second-leading cause of death in the United States and is expected to become the leading cause of death in the next decade. To refocus nationwide efforts, the ACS has assessed the successes and challenges in cancer control and oncology, identifying key issues that must be addressed and what interventions must be implemented to most efficiently control cancer. The series will focus on areas such as prevention, screening and early detection, cancer care and treatment, and research.

The first article, now published, assesses progress thus far in cancer control by reviewing trends in cancer mortality and disparities in cancer outcomes. It highlights mortality trends for several cancers that demonstrate successes and challenges in cancer control, and describes gaps in cancer mortality by race/ethnicity, economic and educational level, and region of residence. The report concludes: "Assessment of the outcomes data clearly demonstrates one vital fact. We can do better."

One area of critical disparity is in socioeconomic status. Using educational attainment as a surrogate of socioeconomic status, ACS epidemiologists in this report estimate that one in four current cancer deaths would not occur if all Americans had the cancer death rate of college educated Americans. Applying the death rate for the most educated group (bachelor's degree or above) to the entire population would lead to 59% fewer lung cancer deaths, 32% fewer colorectal cancer deaths, 19% fewer pancreas cancer deaths, and 50% fewer liver cancer deaths. In total, more than 150,000 of the estimated 610,000 cancer deaths in the U.S. in 2018 would not occur if all Americans had the same levels of cancer risk exposure and received the same amount and quality of care as college graduates.

"This calculation speaks volumes," write the authors. "The statistics demonstrate our obligation to deliver the fruits of already completed research to all Americans. They tell us what can be accomplished in cancer control without the development of new technology, new screening tests or new treatments."
-end-
Not peer-reviewed, Editorial/Literature Review

Articles: Brawley OW, Gansler T, Wender RC (2018). Toward the Control of Cancer. CA Cancer J Clin. doi:10.3322/caac.21461 and Siegel RL, Jemal A, Wender RC, et al (2018). An Assessment of Progress in Cancer Control. CA Cancer J Clin. doi:10.3322/caac.21460

American Cancer Society

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.